Share Price.com
Share Search

Silence Ther. Share Price


Share Price: 59.00   Bid / Ask: 58.50 / 59.50   High: 59.50   Low: 59.50



Silence Ther. is listed on the London Stock Exchange with ticker code SLN, and is part of the Pharmaceuticals & Biotechnology sector. It has a market capitalisation of £41.93 m, with 71,069,933 shares in issue. Over the last year, Silence Ther. has traded in a range of 135.00p, peaking at a high of 175.00p, with a low of 40.00p.


Silence Ther. Share Price Value

Silence Ther. Share Price
Silence Ther.
Price59.00
Short CodeSLN
Change Today0.00
%ge Change0.00 %
Time05:30:01
High59.50
Low59.50
Open59.50
Yesterdays Close59.00
Volume Traded Today0
Silence Ther. Share Price
Intra-day chart for Silence Ther.
Silence Ther. Intraday Chart
Silence Ther. Intraday graph
Silence Ther. Intraday Chart


Today’s Trade Volumes for Silence Ther.

Recent Trades for SLN

Recent Share Trades for Silence Ther. (SLN) (streaming)

Date
Time
Trade Prc
Volume
Value (approx)
18-Apr-19
13:36:29
59.50
1,000
595.00
18-Apr-19
13:36:29
59.50
4,000
2,380
18-Apr-19
13:35:56
59.50
4,675
2,782
18-Apr-19
13:35:56
59.50
4,000
2,380
18-Apr-19
13:35:56
59.50
1,325
788.38
18-Apr-19
13:34:42
59.50
5,000
2,975
18-Apr-19
13:33:56
59.50
5,000
2,975
18-Apr-19
13:33:11
59.50
5,000
2,975
18-Apr-19
13:20:38
59.50
1,875
1,116


6 Month Graph for Silence Ther.

Silence Ther. 6 month graph

Share News for Silence Ther.

HeadlineDate
Silence Therapeutics interim chairman Andy Richards stands downTuesday
Silence Therapeutics appoints Giles Campion as chief medical officerTuesday
Silence Therapeutics applies to commence clinical trial of iron overload treatment27 Mar '19
Silence Therapeutics losses deepen as R&D spending mounts11 Mar '19
Silence Therapeutics treatment granted orphan drug status in Europe15 Jan '19
Silence Therapeutics CFO David Ellam stands down9 Jan '19
Miners lift FTSE as Wall Street anticipates US interest rate hike 19 Dec '18
UK stocks open 0.3% higher; buoyed by GSK merger news19 Dec '18
Silence Therapeutics identifies new potential treatment for heart disease19 Dec '18
Silence Therapeutics agrees settlement, licencing deal with Alnylam Pharmaceuticals10 Dec '18



Useful information about Silence Ther.



Share Search
Share Search Share Search

Visit the Share Search.
Share Search

Share News
Share News



SharePrice.com will do their best to ensure the quality of the information displayed on this site, but all information is provided as-is, free of charge. We cannot be held responsible for any loss, material or otherwise, due to incorrect information found here. UK data supplied by NBTrader and Digital Look. Share Prices are at least 15 minutes delayed.